MOLECULAR MECHANISMS OF RETINA SPECIFIC GENE EXPRESSION
视网膜特异性基因表达的分子机制
基本信息
- 批准号:2608669
- 负责人:
- 金额:$ 21.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-12-01 至 1999-11-30
- 项目状态:已结题
- 来源:
- 关键词:DNA binding protein RNase protection assay SDS polyacrylamide gel electrophoresis affinity chromatography cell type congenital eye disorder gel mobility shift assay gene expression immunoprecipitation in situ hybridization molecular cloning molecular genetics molecular pathology northern blottings polymerase chain reaction protein purification protein structure function retina retina disorder rhodopsin tissue /cell culture transcription factor western blottings yeast two hybrid system
项目摘要
Differential expression of genes in a particular tissue, such as
retina, is achieved by combinatoriaI action of transcription factors.
Nrl is an evolutionarily-conserved bZIP transcription factor,
identified in our laboratory by subtraction cloning. In the adult, high
levels of Nrl transcripts are detected only in the retina. The Nrl
protein shows strong homology to the product of a transforming
oncogene, v-maf. The proteins of the Maf-Nrl subfamily recognize a long
AP-1 like DNA sequence element, are shown to heterodimerize with
selected bZIP proteins in vitro, and implicated in tissue-specific gene
regulation. Several lines of evidence suggest that Nrl is involved in
rhodopsin gene regulation. The underlying hypothesis is that in the
adult retina Nrl plays a major role in regulating the expression of
gene products that are needed for the appropriate fiinctioning of
photoreceptors and other neurons. Since protein-protein interactions
are a major determinant of transcriptional activity and can generate
tremendous flexibility in target site selection, the objective of this
proposal is to identify the proteins that specifically interact with
Nrl and to elucidate the biological relevance of these interactions.
To accomplish this, Specific Aim 1 proposes to evaluate whether any of
the known bZIP proteins of the Fos, Jun, Maf-Nrl and NF-E2 p45
subfamilies is expressed in the adult retina and interacts with Nrl to
modulate gene expression. Specific Aim 2 focuses on the purification
and characterization of retinal proteins that bind to the Nrl-response
element in the rhodopsin promoter. Specific Aim 3 employs a yeast two-
hybrid approach with the "Nrl-bZIP bait" to identify the proteins that
productively heterodimerize with Nrl and may be involved in regulating
different sets of genes in the retina.
The long-term objective of P.I.'s research is to understand the
molecular events involved in the pathogenesis of eye diseases and
eventually assist in the design of gene-based therapeutic strategies.
Transcription factors have become attractive targets for mechanism-
based design of drugs, which can be used to modulate specific
biochemical pathways. In that direction, the proposed studies are
designed to identify transcriptional regulatory proteins that together
with Nrl mediate tissue- or cell type- specific gene expression in the
retina, and should provide mechanistic insights into the molecular
basis of congenital and inherited retinal disorders.
基因在特定组织中的差异表达,例如
视网膜,是通过转录因子的组合定向作用实现的。
Nrl是进化上保守的bZIP转录因子,
在我们的实验室通过消减克隆鉴定。在成年人中,高
仅在视网膜中检测到Nr 1转录物的水平。全国劳资关系委员会
蛋白质显示出与转化产物的强同源性,
癌基因v-maf。Maf-Nrl亚家族的蛋白质识别长的
AP-1样DNA序列元件,显示与
选择bZIP蛋白在体外,并牵连在组织特异性基因
调控几条证据表明,Nrl参与了
视紫红质基因调控 潜在的假设是,
成人视网膜Nrl在调节
基因产物,需要适当的fintioning
光感受器和其他神经元。 由于蛋白质-蛋白质相互作用
是转录活性的主要决定因素,
在目标地点的选择上具有巨大的灵活性,
建议是识别与特定蛋白质相互作用的蛋白质
并阐明这些相互作用的生物学意义。
为了实现这一目标,具体目标1建议评估是否有任何
已知的Fos、Jun、Maf-Nrl和NF-E2 p45的bZIP蛋白
亚家族在成人视网膜中表达,并与Nrl相互作用,
调节基因表达。具体目标2侧重于纯化
以及与Nr 1反应结合的视网膜蛋白的表征
视紫红质启动子中的元素。具体目标3采用酵母双-
使用“Nrl-bZIP诱饵”的混合方法来鉴定
与Nrl产生异二聚体,并可能参与调节
视网膜中不同的基因组
P.I.的长期目标。的研究是为了了解
参与眼病发病机制的分子事件,
最终帮助设计基于基因的治疗策略。
转录因子已成为有吸引力的目标机制-
基于药物设计,可用于调节特定的
生化途径在这方面,拟议的研究是
旨在识别转录调节蛋白,
与Nrl介导的组织或细胞类型特异性基因表达,
视网膜,并应提供机制的见解,分子
先天性和遗传性视网膜疾病的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANAND SWAROOP其他文献
ANAND SWAROOP的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANAND SWAROOP', 18)}}的其他基金
Genetic Variations in Age-related Macular Degeneration
年龄相关性黄斑变性的遗传变异
- 批准号:
7094436 - 财政年份:2006
- 资助金额:
$ 21.52万 - 项目类别:
MOLECULAR GENETICS OF RETINAL DEVELOPMENT AND INHERITED EYE DISEASE
视网膜发育和遗传性眼病的分子遗传学
- 批准号:
6113354 - 财政年份:1998
- 资助金额:
$ 21.52万 - 项目类别:
MOLECULAR GENETICS OF RETINAL DEVELOPMENT AND INHERITED EYE DISEASE
视网膜发育和遗传性眼病的分子遗传学
- 批准号:
6297131 - 财政年份:1998
- 资助金额:
$ 21.52万 - 项目类别:
MOLECULAR GENETICS OF RETINAL DEVELOPMENT AND INHERITED EYE DISEASE
视网膜发育和遗传性眼病的分子遗传学
- 批准号:
6274588 - 财政年份:1997
- 资助金额:
$ 21.52万 - 项目类别:
MOLECULAR GENETICS OF RETINAL DEVELOPMENT AND INHERITED EYE DISEASE
视网膜发育和遗传性眼病的分子遗传学
- 批准号:
6244531 - 财政年份:1997
- 资助金额:
$ 21.52万 - 项目类别:
MOLECULAR MECHANISMS OF RETINA-SPECIFIC GENE EXPRESSION
视网膜特异性基因表达的分子机制
- 批准号:
6476380 - 财政年份:1996
- 资助金额:
$ 21.52万 - 项目类别:
MOLECULAR MECHANISMS OF RETINA-SPECIFIC GENE EXPRESSION
视网膜特异性基因表达的分子机制
- 批准号:
6693055 - 财政年份:1996
- 资助金额:
$ 21.52万 - 项目类别:
Molecular Mechanisms of Retina-specific Gene Expression
视网膜特异性基因表达的分子机制
- 批准号:
7171799 - 财政年份:1996
- 资助金额:
$ 21.52万 - 项目类别:
MOLECULAR MECHANISMS OF RETINA SPECIFIC GENE EXPRESSION
视网膜特异性基因表达的分子机制
- 批准号:
2019993 - 财政年份:1996
- 资助金额:
$ 21.52万 - 项目类别:
相似海外基金
NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
- 批准号:
6317727 - 财政年份:2000
- 资助金额:
$ 21.52万 - 项目类别: